SÜLFÜR MUSTARDIN GLUTATYON BAĞIMLI β-LİYAZ METABOLİTLERİNİN DÖRT FARKLI TİP IN VITRO HÜCRE KÜLTÜR MODELİ ÜZERİNDEKİ SİTOTOKSİK ETKİLERİNİN DEĞERLENDİRİLMESİ

Giriş: Sülfür mustard (SM) alkilleyici özelliği çok güçlü bir yakıcı ajan ve aynı zamanda yasaklanmış bir kimyasal harp maddesidir. SBMTE, MSMTESE ve SBMSE; SM’ın glutatyon bağımlı β-liyaz metabolitleridir. Bu çalışmanın amacı; β-liyaz metabolitlerinin sitotoksik etkilerini dört farklı tip in vitro insan hücre hattı üzerinde değerlendirmektir. Gereç ve Yöntem: İnsan retina pigment epitel hücre hattı, insan umbilikal ven endotel hücre hattı, insan oral keratinosit hücre hattı ve insan akciğer fibroblast hücre hattı beş farklı konsantrasyondaki (10, 50, 100, 500, and 1000 ng/mL) SBMTE, MSMTESE ve SBMSE’ye maruz bırakılmıştır. β-liyaz metabolitlerinin sitotoksik etkisi; maruziyetten 24, 48 ve 72 saat sonra yapılan MTT testlerinde yaşayan hücrelerin yüzdelerine göre tespit edilmiştir. Bulgular: SBMTE, MSMTESE ve SBMSE’nin farklı konsantrasyonlarının dört farklı hücre kültür modelinde 24, 48 ve 72 saatteki sitotoksik etkileri değerlendirildiğinde, yaşayan hücrelerin yüzdeleri anlamında istatistiki olarak anlamlı bir fark bulunmamıştır (p> 0.05). Sonuç: β-liyaz metabolitlerinin; SM’ın ana hedefi olan bu grup hücrelerde ortaya çıkan sitotoksik etkilerden doğrudan sorumlu olmadığı değerlendirilmektedir. Bulgularımız; SM maruziyeti sonrasında β-liyaz metabolitlerinin oksidan/antioksidan denge üzerindeki etkilerini anlamak için hayvan modellerinde kullanılabilir. Böylece SM kurbanlarının tedavisinde kullanılabilecek potansiyel antioksidan ajanların etkinlikleri değerlendirilebilir.

EVALUATION OF CYTOTOXICITY OF GLUTATHIONE DERIVED β-LYASE METABOLITES OF SULFUR MUSTARD ON FOUR DIFFERENT TYPES OF IN VITRO CELL CULTURE MODEL

Introduction: Sulfur mustard (SM) is an extremely alkylating vesicant agent and it is also a banned chemicalwarfare agent. SBMTE, MSMTESE, and SBMSE are glutathione derived β-lyase metabolites of SM. The aim ofthis study was to evaluate the cytotoxic effects of β-lyase metabolites on four different types of in vitro human celllines.Material and Methods: The human retinal pigmented epithelium cell line, human primary umbilical veinendothelial cell line, human oral keratinocytes cell line, and human lung fibroblast cell line were exposed to five different concentrations (10, 50, 100, 500, and 1000 ng/mL) of SBMTE, MSMTESE, and SBMSE. The cytotoxiceffects of β-lyase metabolites were determined at 24, 48, and 72 hours (h) after the exposure by MTT assay asviability rate “%”.Results: When the cytotoxic effects of different concentrations of SBMTE, MSMTESE, and SBMSE on four cellculture model at 24th, 48th, and 72th h were evaluated, there was no statistically significant difference found inmean of cell viability (p> 0.05).Conclusion: It is concluded that β-lyase metabolites are not directly responsible for the toxicity occurring in thesegroup of cells which are main targets of SM. Our findings could be used for understanding the effects of β-lyasemetabolites on oxidant/antioxidant balance after SM exposure in animal models. By this way, effectiveness ofpotential antioxidant agents for the treatment of victims of SM exposure could be evaluated.

___

  • 1. Lin Y, Dong Y, Chen J, Li CZ, Nie ZY, Guo L, et al. Gas chromatographic-tandem mass spectrometric analysis of beta-lyase metabolites of sulfur mustard adducts with glutathione in urine and its use in a rabbit cutaneous exposure model. J Chromatogr B 945 (2014): 233-239.
  • 2. Ruszkiewicz JA, Burkle A, Mangerich A. NAD(+) in sulfur mustard toxicity. Toxicol Lett 324 (2020): 95-103.
  • 3. Mangerich A, Esser C. Chemical warfare in the First World War: reflections 100 years later. Arch Toxicol 2014; 88(11): 1909-11.
  • 4. Kilic E, Ortatatli M, Sezigen S, Eyison RK, Kenar L. Acute intensive care unit management of mustard gas victims: the Turkish experience. Cutan Ocul Toxicol 2018; 37(4): 332-7.
  • 5. Sezigen S, Eyison RK, Kilic E, Kenar L. Evidence of sulfur mustard exposure in victims of chemical terrorism by detection of urinary beta-lyase metabolites. Clin Toxicol (Phila) 2020; 58(1): 36-44.
  • 6. Sezigen S, Ivelik K, Ortatatli M, Almacioglu M, Demirkasimoglu M, Eyison RK, et al. Victims of chemical terrorism, a family of four who were exposed to sulfur mustard. Toxicol Lett 303 (2019): 9-15.
  • 7. Hassan ZM, Ebtekar M, Ghanei M, Taghikhani M, Noori Daloii MR, Ghazanfari T. Immunobiological consequences of sulfur mustard contamination. Iran J Allergy Asthma Immunol 2006; 5(3): 101-8.
  • 8. Balali M. Clinical and laboratory findings in Iranian fighters with chemical gas poisoning. Arch Belg 1984; supp: 254-9.
  • 9. Khateri S, Ghanei M, Keshavarz S, Soroush M, Haines D. Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent. J Occup Environ Med. 2003;45(11):1136-43.
  • 10. Rowell M, Kehe K, Balszuweit F, Thiermann H. The chronic effects of sulfur mustard exposure. Toxicology. 2009;263(1):9- 11.
  • 11. Ghabili K, Agutter PS, Ghanei M, Ansarin K, Shoja MM. Mustard gas toxicity: the acute and chronic pathological effects. J Appl Toxicol 2010; 30(7): 627-43.
  • 12. Beigi Harchegani A, Mirnam Niha M, Sohrabiyan M, Ghatrehsamani M, Tahmasbpour E, Shahriary A. Cellular and molecular mechanisms of sulfur mustard toxicity on spermatozoa and male fertility. Toxicol Res (Camb) 2018; 7(6):1029-35.
  • 13. Eyison RK, Sezigen S, Ortatatli M, Kenar L. Optimized Gas Chromatography-Tandem Mass Spectrometry for 1,1'- sulfonylbis[2-(methylthio) ethane] Quantification in Human Urine. J Chromatogr Sci 2019; 57(5): 397-402.
  • 14. Black RM, Hambrook JL, Howells DJ, Read RW. Biological fate of sulfur mustard, 1,1'-thiobis(2-chloroethane). Urinary excretion profiles of hydrolysis products and beta-lyase metabolites of sulfur mustard after cutaneous application in rats. J Anal Toxicol 1992;16(2):79-84.
  • 15. Young CL, Ash D, Driskell WJ, Boyer AE, Martinez RA, Silks LA, et al. A rapid, sensitive method for the quantitation of specific metabolites of sulfur mustard in human urine using isotope-dilution gas chromatography-tandem mass spectrometry. J Anal Toxicol 2004; 28(5): 339-45.
  • 16. Anslow WP, Jr., Karnofsky DA, et al. The intravenous, subcutaneous and cutaneous toxicity of bis (beta-chloroethyl) sulfide (mustard gas) and of various derivatives. J Pharmacol Exp Ther 1948; 93(1):1-9.
  • 17. Paromov V, Qui M, Yang H, Smith M, Stone WL. The influence of N-acetyl-L-cysteine on oxidative stress and nitric oxide synthesis in stimulated macrophages treated with a mustard gas analogue. BMC Cell Biol 2008; 9(1): 33.
  • 18. Ghabili K, Agutter PS, Ghanei M, Ansarin K, Panahi Y, Shoja MM. Sulfur mustard toxicity: History, chemistry, pharmacokinetics, and pharmacodynamics. Crit Rev Toxicol 2011;41(5): 384-403.
  • 19. Sezigen S, Eyison RK, Kenar L. Bioanalytical verification of sulfur mustard exposure in a Syrian family. Gulhane Medical Journal 2019; 61(2);64-8.
  • 20. Xu H, Nie Z, Zhang Y, Li C, Yue L, Yang W et al. Four sulfur mustard exposure cases: Overall analysis of four types of biomarkers in clinical samples provides positive implication for early diagnosis and treatment monitoring. Toxicol Rep 2014;1:533-43.
  • 21. Menacher G, Steinritz D, Schmidt A, Popp T, Worek F, Gudermann T et al. Effects of anti-inflammatory compounds on sulfur mustard injured cells: Recommendations and caveats suggested by in vitro cell culture models. Toxicol Lett 2018; 293 :91-7.
İzmir Eğitim ve Araştırma Hastanesi Tıp Dergisi-Cover
  • ISSN: 1305-5151
  • Başlangıç: 1995
  • Yayıncı: İzmir Bozyaka Eğitim ve Araştırma Hastanesi
Sayıdaki Diğer Makaleler

VITAMIN D, PARATHORMONE, GENDER, INTERLEUKIN 10 AND TUMOR NECROSIS ALPHA RELATIONSHIP IN MULTIPLE SCLEROSIS PATIENTS

Pınar BEKDİK ŞİRİNOCAK, Neslihan EŞKUT, Ayfer ÇOLAK, Ufuk ŞENER, Yaşar ZORLU

SURGICAL RESECTION OF TUMORS LOCATED IN THE INSULAR REGION

Emrah AKÇAY, Hakan YILMAZ, Hüseyin Berk BENEK, Alper TABANLI, Alaettin YURT

SABAH VE ÖĞLEDEN SONRA YAPILAN EGZERSİZİN GHRELİN VE VASPİN DÜZEYLERİNE ETKİSİ

Servet KIZILDAĞ, Ferda HOŞGÖRLER

ÖZOFAGUS-MİDE MALİGNİTELERİNDE REZEKSİYONDAN VE FORMOL FİKSASYONUNDAN SONRA OLUŞAN CERRAHİ SINIR KISALMALARININ DEĞERLENDİRİLMESİ VE DÜZELTME FAKTÖRÜ YARATILMASI: PROSPEKTİF BİR ÇALIŞMA

Mehmet YILDIRIM, Enver İLHAN, Ozan Barış NAMDAROĞLU, Ahmet AYKAS, Orhan ÜREYEN, Savaş YAKAN, Adam USLU, Yasemin ŞAHİN, Enver VARDAR

EVALUATION OF CYTOTOXICITY OF GLUTATHIONE DERIVED β-LYASE METABOLITES OF SULFUR MUSTARD ON FOUR DIFFERENT TYPES OF IN VITRO CELL CULTURE MODEL

Ruşen Koray EYİSON, AHU PAKDEMİRLİ, Meral SARPER, Sermet SEZİGEN, Levent KENAR

ÇOKLU BİLEŞENİNDEN DOLAYI DİREKT SAĞLIK MALİYETLERİ YANIK MERKEZİNDE SORUN OLMAYA DEVAM EDİYOR MU?

Mehmet YILDIRIM, Ahmet Deniz UÇAR, Erkan OYMACI

NADİR GÖRÜLEN BİR İLEUS SEBEBİ: ABDOMİNAL KOZA SENDROMU

Cengiz AYDIN, Yasemin KIRMIZI, Semra Demirli ATICI, Tayfun KAYA, Can ARICAN, Erdal HARMANDA

THE INVESTIGATION OF THE MPTP TREATMENT AND THE MONOAMINE OXIDASE B EXPRESSION LEVELS IN GLIOBLASTOMA CELL LINES

GİZEM DÖNMEZ YALÇIN

DOES DIRECT HEALTHCARE COSTS CONTINUE TO BE A PROBLEM IN THE BURN CENTER DUE TO MANY COMPONENTS?

Mehmet YILDIRIM, Ahmet Deniz UÇAR, Erkan OYMACI

PARKİNSON HASTALIĞI TEDAVİSİNDE İLACA BAĞLI DÜRTÜ KONTROL BOZUKLUĞU

Nazlı DURMAZ ÇELİK, Müge KUZU KUMCU, Seda BOSTAN, Serhat ÖZKAN